Please provide your email address to receive an email when new articles are posted on . In a randomized double blind, placebo-controlled trial with older men assigned either AndroGel 1% (transdermal ...

For women, the onset of midlife brings with it an array of distressing symptoms related to changes in hormone levels. The risk of dementia increases with age – particularly after the mid-60s – memory ...

There is still considerable controversy concerning the role of androgen therapy for hypoactive sexual desire disorder in females. Clinical trials have shown that exogenous testosterone therapy ...

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Transdermal Delivery Solutions Corporation (TDSC) announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...

RALEIGH, N.C.--(BUSINESS WIRE)--Marius Pharmaceuticals, a specialty pharmaceutical company focusing on treating conditions that are primarily associated with testosterone deficiency, today announced ...

The U.S. Food and Drug Administration today announced that it is requiring manufacturers of two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on ...

This patent application has not been assigned to a company or institution. The following quote was obtained by the news editors from the background information supplied by the inventors: "With the ...

Testosterone is a vital male hormone that is responsible for the development and maintenance of male attributes. Women also have testosterone, but in much smaller amounts. Testosterone is an important ...

Effects of exogenous testosterone on the circadian system of the male domestic canary (Serinus canaria) were studied in light:dark (L:D) cycles with 16 h of bright light (ca. 35 lx) and 8 h of dim ...

Hypogonadal.com launches as a global educational platform providing science-backed information about hypogonadism. Founded by ...